Home » Stocks » QLI

Qilian International Holding Group Limited (QLI)

Stock Price: $4.21 USD 0.03 (0.72%)
Updated Apr 19, 2021 11:48 AM EDT - Market open
Market Cap 147.35M
Revenue (ttm) 50.03M
Net Income (ttm) 5.06M
Shares Out 35.00M
EPS (ttm) 0.14
PE Ratio 29.10
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 19
Last Price $4.21
Previous Close $4.18
Change ($) 0.03
Change (%) 0.72%
Day's Open 4.18
Day's Range 4.14 - 4.30
Day's Volume 23,159
52-Week Range 4.10 - 22.00

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Jiuquan, China, April 13, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announ...

6 days ago - GlobeNewsWire

Jiuquan, China, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announc...

2 months ago - GlobeNewsWire

Jiuquan, China, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announc...

2 months ago - GlobeNewsWire

New York, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, is a full-service investment bank and securities broker-dealer firm based in New York, today ...

3 months ago - GlobeNewsWire

Jiuquan, China, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (the “Company”) (Nasdaq: QLI), a China-based pharmaceutical and chemical products manufacturer, today announc...

3 months ago - GlobeNewsWire

Qilian (QLI) is catching the eyes of investors on Tuesday as shares of its stock started trading today via the company's IPO. The post Qilian IPO: 10 Things for Potential QLI Stock Investors to Know Abo...

3 months ago - InvestorPlace

Jiuquan, China, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announced the pricing...

3 months ago - GlobeNewsWire

About QLI

Qilian International is a pharmaceutical and chemical company based in China that focuses on the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (“TCMD”) product, heparin product, sausage casings, and fertilizers. We independently developed Gan Di Xin® and Ahan® Antibacterial Paste within our research and development department. Our products are sold in more than 20 provinces in China.

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Jan 12, 2021
CEO
Zhanchang Xin
Employees
292
Stock Exchange
NASDAQ
Ticker Symbol
QLI
Full Company Profile

Financial Performance

In 2020, QLI's revenue was $50.03 million, an increase of 8.54% compared to the previous year's $46.10 million. Earnings were $5.06 million, a decrease of -5.04%.

Financial Statements